Global X AgTech and Food Innovation ETF (KROP)
Live price chart, market sentiment, and community perspectives for Global X AgTech and Food Innovation ETF (NASDAQ: KROP).
Live price chart, market sentiment, and community perspectives for Global X AgTech and Food Innovation ETF (NASDAQ: KROP).
On our desk, we are monitoring the structural positioning of the Global X AgTech and Food Innovation ETF (KROP). With its inception dating back to July 12, 2021, and a fixed expense ratio of 0.50%, it represents a specialized niche product. Market sentiment remains cautiously balanced, reflected by Danelfin's AI model issuing a moderate score of 5/10, categorized as low risk. We are tracking liquidity patterns closely around its recent daily trading range between $36.90 and $37.25 observed in late August 2026.
Reviewing the quantitative metrics for KROP, the fund provides targeted exposure to companies driving technological advancements in agriculture and food innovation. While the 0.50% expense ratio is standard for thematic ETFs from Global X, prospective allocators must weigh the broader market headwinds against its specific sector drivers. Recent dividend distributions, such as the ex-dividend event scheduled for late June 2026 with a payout of $0.13515 per share, offer a minor yield component for long-term holders.
When evaluating KROP for quantitative portfolios, our focus centers on how its underlying basket adapts to cyclical shifts in agriculture. Since the ETF targets agtech and food innovation, analysts should review historical growth trends and Morningstar ratings to gauge risk-adjusted performance. The combination of a 5/10 AI sentiment score and stable price action around the mid-$37 mark suggests that the asset is currently range-bound, requiring tighter risk management protocols for short-term tactical allocations.
From a macro sentiment perspective, KROP continues to capture interest among investors looking for thematic exposure to food innovation. However, public forum chatter indicates that adoption speed among institutional investors remains measured. The fund's ability to maintain stable pricing through mid-2026 sessions—hitting highs near $37.25—demonstrates a resilient floor, though upside catalysts appear muted in the absence of broader sector-wide regulatory or technological breakthroughs.
In our quantitative research group, assessing KROP involves parsing its historical growth metrics since its July 2021 inception. The 0.50% expense ratio places it in line with specialized thematic ETFs, but the real test lies in its underlying constituents' revenue growth. With recent daily quotes oscillating in a tight band between $36.90 and $37.25, technicians are watching for a definitive breakout above the upper bound before recommending increased position sizing.
Explore plasma cleansing, somatic organ swaps, and BCI.